BridgeMD
New treatment option for Cardiopulmonary Arrest
Official title REBOA in Nontraumatic OHCA
ClinicalTrials.gov ID: NCT06031623
What this study is testing
- What it's testing
- The investigators propose a multicenter randomized controlled trial in South Korea and Taiwan to observe the clinical effects of REBOA on nontraumatic out-of-hospital-cardiac-arrest (OHCA) patients. While REBOA has been traditionally used in trauma for hemorrhage control, it has also shown promising results in nontraumatic cardiac arrests by rerouting circulation to increase perfusion in the coronary and brain.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 80
You may be able to join if
- Adult nontraumatic OHCA
- Witnessed arrest
- Arrival at ER from 9AM to 5PM (in South Korea) and 8AM to 8PM (in Taiwan)
You likely can't join if
- age below 20 years old or over 80 years old,
- traumatic cardiac arrest,
- those with unwitnessed cardiac arrest,
- pregnant patients,
- patients who have already achieved ROSC upon arrival at the emergency department
- pre-cardiac arrest cerebral performance category of 3-4
See the full eligibility criteria
- Adult nontraumatic OHCA
- Witnessed arrest
- Arrival at ER from 9AM to 5PM (in South Korea) and 8AM to 8PM (in Taiwan)
- age below 20 years old or over 80 years old,
- traumatic cardiac arrest,
- those with unwitnessed cardiac arrest,
- pregnant patients,
- patients who have already achieved ROSC upon arrival at the emergency department
- pre-cardiac arrest cerebral performance category of 3-4
- those showing evidence of cardiac arrest due to bleeding (such as gastrointestinal bleeding)
- those suspected of having aortic disease, such as dissection, intramural hematoma, or aneurysm, by bedside ultrasound performed immediately after ED arrival or have a previous history of aortic disease
- whose legal representative has requested termination of resuscitation efforts before study enrollment
- declared dead at scene before randomization
- Patients who meet the criteria for extracorporeal cardiopulmonary resuscitation (ECPR), and therefore the decision is made to perform ECPR, will not be enrolled. The ECPR criteria applies when all of the following...
The study team makes the final eligibility decision.
Where it's taking place
- Seongnam-si, Gyeonggi-do, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seongnam-si, Gyeonggi-do, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.